These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Shah AR; Agarwal SK; Shah KV Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118 [TBL] [Abstract][Full Text] [Related]
6. E-test: an alternative method for susceptibility testing of Mycobacterium tuberculosis. Akcali S; Cicek C; Surucuoglu S; Ozbakkaloglu B Med Princ Pract; 2005; 14(4):264-7. PubMed ID: 15961938 [TBL] [Abstract][Full Text] [Related]
7. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
8. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis]. Zierski M; Bek E Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146 [No Abstract] [Full Text] [Related]
9. [New guidelines for pulmonary tuberculosis therapy]. Steiner A; Medici TC Dtsch Med Wochenschr; 1978 Mar; 103(9):372-5. PubMed ID: 631063 [No Abstract] [Full Text] [Related]
10. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods]. Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962 [TBL] [Abstract][Full Text] [Related]
11. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Jindani A; Doré CJ; Mitchison DA Am J Respir Crit Care Med; 2003 May; 167(10):1348-54. PubMed ID: 12519740 [TBL] [Abstract][Full Text] [Related]
12. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3. Oka S; Sasaki M; Kobayashi T; Matsuda T Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627 [No Abstract] [Full Text] [Related]
13. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya]. Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678 [No Abstract] [Full Text] [Related]
14. Chemotherapy of tuberculosis. Pinsker KL; Koerner SK Am J Hosp Pharm; 1976 Mar; 33(3):275-83. PubMed ID: 769544 [TBL] [Abstract][Full Text] [Related]
15. A simple and economical in-house phage technique for the rapid detection of rifampin, isoniazid, ethambutol, streptomycin, and ciprofloxacin drug resistance in Mycobacterium tuberculosis, directly on decontaminated sputum samples. Hemvani N; Patidar V; Chitnis DS Int J Infect Dis; 2012 May; 16(5):e332-6. PubMed ID: 22369736 [TBL] [Abstract][Full Text] [Related]
16. Utilization of antituberculosis drugs expressed in defined daily doses in Klenovnik Hospital in the period between 1983 and 1987. Trkanjec Z; Tekavec J Tuber Lung Dis; 1993 Feb; 74(1):16-9. PubMed ID: 8495013 [TBL] [Abstract][Full Text] [Related]
17. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990]. Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309 [No Abstract] [Full Text] [Related]
18. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis. Kothadia SN; Sengupta SR Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608 [No Abstract] [Full Text] [Related]
19. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]. Yoshiyama T; Ogata H; Ito K; Aono A; Wada M Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318 [TBL] [Abstract][Full Text] [Related]